Ilian Iliev

Dr. Ilian Iliev, Chief Executive Officer, is Managing Director of EMV Capital (EMVC), a corporate finance and VC investment firm acquired by NetScientific in August 2020. EMVC is a London-based investor in the industrial sustainability, industrials and healthcare sectors. EMVC’s investments in Europe, Israel, and the US cover a range of technologies including robotics and AI, machine learning, materials science, IoT, advanced engineering, power electronics, and medical devices. Ilian spun out EMV Capital out of EcoMachines Ventures, which he co-founded in 2013. Prior to that he co-founded and was CEO of CambridgeIP Ltd (2006-2012), which he built into a leading market and technology business intelligence provider in the UK. He is a Board member at a number of Net Scientific and EMVC portfolio companies, including PDS Biotechnology Inc., Glycotest Inc., Sofant Technologies, Pointgrab, Q-Bot, and Wanda Health, and also serves as Executive Chairman at Vortex Biosciences Inc.

Ilian holds a Ph.D. from Cambridge University’s Judge Business School, focused on Venture Capital business models in emerging economies, Mcom in Economics, and a BA in Politics, Economics, and International Relations from the University of Witwatersrand, South Africa. He has published widely on entrepreneurship, venture capital, and market trends in energy and healthcare, and has won awards for academic excellence.